Surgery Partners, Inc., through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and a suite of ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of March 12, 2018, the company operated approximately 180 locations in 32 states, including ambulatory surgery centers, surgical hospitals, a diagnostic laboratory, multi-specialty physician practices, and urgent care facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorMedical
Phone615-234-5900
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.34 billion
Profitability
Miscellaneous
Employees10,600
Next Earnings Date5/8/2019 (Estimated)
OptionableOptionable
Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions
What is Surgery Partners' stock symbol?
Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."
How will Surgery Partners' stock buyback program work?
Surgery Partners declared that its board has initiated a stock repurchase plan on Saturday, December 16th 2017, which permits the company to repurchase $50,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's leadership believes its shares are undervalued.
How were Surgery Partners' earnings last quarter?
Surgery Partners Inc (NASDAQ:SGRY) announced its quarterly earnings results on Wednesday, March, 13th. The company reported ($0.74) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.01 by $0.75. The firm had revenue of $491.20 million for the quarter, compared to analysts' expectations of $485.35 million. Surgery Partners had a negative net margin of 5.55% and a negative return on equity of 1.68%. The firm's revenue was up 6.7% compared to the same quarter last year. During the same period last year, the business earned ($0.03) EPS. View Surgery Partners' Earnings History.
When is Surgery Partners' next earnings date?
What guidance has Surgery Partners issued on next quarter's earnings?
Surgery Partners updated its FY 2018 earnings guidance on Monday, January, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.75-1.8 billion, compared to the consensus revenue estimate of $1.79 billion.
What price target have analysts set for SGRY?
5 brokers have issued 12-month price objectives for Surgery Partners' stock. Their predictions range from $15.00 to $25.00. On average, they expect Surgery Partners' stock price to reach $18.75 in the next year. This suggests a possible upside of 37.7% from the stock's current price. View Analyst Price Targets for Surgery Partners.
What is the consensus analysts' recommendation for Surgery Partners?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Surgery Partners.
Has Surgery Partners been receiving favorable news coverage?
Media headlines about SGRY stock have trended somewhat positive recently, according to InfoTrie. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Surgery Partners earned a news sentiment score of 1.1 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future.
Who are some of Surgery Partners' key competitors?
Some companies that are related to Surgery Partners include Glaukos (GKOS), Emergent Biosolutions (EBS), Dechra Pharmaceuticals (DPH), LifePoint Health (LPNT), Aphria (APHA), Ligand Pharmaceuticals (LGND), Myriad Genetics (MYGN), Abcam (ABC), Acceleron Pharma (XLRN), National Vision (EYE), Uniqure (QURE), Halozyme Therapeutics (HALO), Mediclinic International (MDC), Denali Therapeutics (DNLI) and Insmed (INSM).
What other stocks do shareholders of Surgery Partners own?
Who are Surgery Partners' key executives?
Surgery Partners' management team includes the folowing people:
- Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 48)
- Mr. Dennis Dean, Exec. Officer (Age 47)
- Mr. Clifford G. Adlerz, Consultant & Director (Age 65)
- Mr. Wayne Scott DeVeydt, CEO & Director (Age 49)
- Mr. Thomas Francis Cowhey, Exec. VP, CFO & Principal Accounting Officer (Age 47)
Who are Surgery Partners' major shareholders?
Surgery Partners' stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (2.97%), Elk Creek Partners LLC (2.67%), Royce & Associates LP (2.14%), AMI Asset Management Corp (1.58%), Dimensional Fund Advisors LP (1.16%) and Dimensional Fund Advisors LP (1.16%). Company insiders that own Surgery Partners stock include Brandan Lingle and HIG Surgery Centers, Llc. View Institutional Ownership Trends for Surgery Partners.
Which major investors are selling Surgery Partners stock?
SGRY stock was sold by a variety of institutional investors in the last quarter, including Northern Trust Corp, MetLife Investment Advisors LLC, Dimensional Fund Advisors LP and Dimensional Fund Advisors LP. View Insider Buying and Selling for Surgery Partners.
Which major investors are buying Surgery Partners stock?
SGRY stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Elk Creek Partners LLC, Millennium Management LLC, Royce & Associates LP, Eaton Vance Management, Squarepoint Ops LLC, Geode Capital Management LLC and Geode Capital Management LLC. View Insider Buying and Selling for Surgery Partners.
How do I buy shares of Surgery Partners?
Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Surgery Partners' stock price today?
One share of SGRY stock can currently be purchased for approximately $13.62.
How big of a company is Surgery Partners?
Surgery Partners has a market capitalization of $665.91 million and generates $1.34 billion in revenue each year. The company earns $-52,980,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. Surgery Partners employs 10,600 workers across the globe.
What is Surgery Partners' official website?
How can I contact Surgery Partners?
Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]
MarketBeat Community Rating for Surgery Partners (NASDAQ SGRY)
MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe SGRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
